We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
+2.89%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$771M
AUM Growth
+$32.5M
Cap. Flow
+$15.2M
Cap. Flow %
1.97%
Top 10 Hldgs %
16.24%
Holding
916
New
72
Increased
419
Reduced
247
Closed
78

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$1.52M
2
VST icon
Vistra
VST
+$1.08M
3
ETP
Energy Transfer Partners, L.P.
ETP
+$1,000K
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$971K
5
AAPL icon
Apple
AAPL
+$804K

Top Sells

Rank Stock Value
1
TRR
Trc Companies
TRR
+$9.24M
2
GGP
GGP Inc.
GGP
+$1.5M
3
CNA icon
CNA Financial
CNA
+$1.04M
4
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$779K
5
CVS icon
CVS Health
CVS
+$759K

Sector Composition

Rank Sector Weight
1 Financials 10.7%
2 Healthcare 10.11%
3 Consumer Discretionary 9.02%
4 Technology 8.48%
5 Industrials 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHK
751
PIMCO High Income Fund
PHK
$861M
$97K 0.01%
+11,138
New +$97.4K
INSG icon
752
Inseego
INSG
$108M
$93K 0.01%
7,462
-1,251
-14% -$19.4K
VVR icon
753
Invesco Senior Income Trust
VVR
$456M
$93K 0.01%
20,383
– –
IAF
754
abrdn Australia Equity Fund
IAF
$120M
$84K 0.01%
4,611
-83
-2% -$1.52K
S
755
DELISTED
Sprint Corporation
S
$83K 0.01%
10,057
-500
-5% -$4.16K
TARA icon
756
Protara Therapeutics
TARA
$226M
$81K 0.01%
1,336
+268
+25% +$15K
TNDM icon
757
Tandem Diabetes Care
TNDM
$1.17B
$80K 0.01%
10,017
+1,833
+22% +$16.9K
ZNGA
758
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$80K 0.01%
21,865
-6,759
-24% -$22.2K
CCEC
759
Capital Clean Energy Carriers
CCEC
$1.4B
$76K 0.01%
3,193
-316
-9% -$7.55K
NVAX icon
760
Novavax
NVAX
$1.23B
$72K 0.01%
3,132
+925
+42% +$18.1K
AUY
761
DELISTED
Yamana Gold, Inc.
AUY
$71K 0.01%
29,241
+18
+0.1% +$49
ABEV icon
762
Ambev
ABEV
$47.3B
$69K 0.01%
12,605
-4,760
-27% -$27.1K
ANTH
763
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$68K 0.01%
41,964
+32,126
+327% +$72K
BGY icon
764
BlackRock Enhanced International Dividend Trust
BGY
$512M
$65K 0.01%
10,300
– –
GASS icon
765
StealthGas
GASS
$328M
$65K 0.01%
19,945
-500
-2% -$1.67K
CLMT icon
766
Calumet Specialty Products
CLMT
$3.63B
$63K 0.01%
14,926
+2,430
+19% +$9.75K
FTR
767
DELISTED
Frontier Communications Corp.
FTR
$63K 0.01%
3,632
-384
-10% -$8.8K
OIG
768
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$61K 0.01%
395
– –
UAN icon
769
CVR Partners
UAN
$1.3B
$60K 0.01%
1,708
-1,754
-51% -$76.4K
SVU
770
DELISTED
SUPERVALU Inc.
SVU
$59K 0.01%
+2,571
New +$68.5K
GNW icon
771
Genworth Financial
GNW
$3.8B
$57K 0.01%
15,020
– –
VHC icon
772
VirnetX Holding Corp
VHC
$52.3M
$55K 0.01%
600
-450
-43% -$32.7K
CCM
773
Concord Medical Services
CCM
$18.7M
$52K 0.01%
1,390
– –
BGMS
774
Bio Green Med Solution Inc
BGMS
$5.05M
– –
0
– –
CHMA
775
DELISTED
Chiasma, Inc. Common Stock
CHMA
$52K 0.01%
36,073
+5,500
+18% +$8.33K
29 30
31
32 33

Similar funds

CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
SI
Sprott Inc Toronto, Ontario, Canada $3.44B AUM 125.26% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return

Wedbush Securities's Q2 2017 Portfolio in Review

As of Q2 2017, Wedbush Securities held 916 positions worth $771M, up 4.4% from $738M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Wedbush Securities's Q2 2017 filing shows 72 new, 419 increased, 247 reduced and 78 closed positions. Its largest new stake was Novo Nordisk: 75,326 shares worth $1.61M. The largest sale was Trc Companies, an estimated $9.24M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Wedbush Securities's largest Q2 2017 buy was Novo Nordisk: 75,326 shares worth $1.61M.
  • Wedbush Securities added most to Apple in Q2 2017, an estimated $804K increase.
  • Wedbush Securities's biggest Q2 2017 reduction was GGP Inc., cutting an estimated $1.5M.
  • Wedbush Securities fully exited Trc Companies in Q2 2017, selling an estimated $9.24M.
  • Wedbush Securities's ten largest holdings make up 16% of its $771M portfolio in Q2 2017.
  • Wedbush Securities opened 72 new positions and closed 78 in Q2 2017.
  • Wedbush Securities's portfolio value rose 4.4% quarter-over-quarter to $771M.

Based on Wedbush Securities's 13F filing for Q2 2017, filed 2 Aug 2017.